News + Filings Holdings
|
VANGUARD GROUP INC
> RVNC
| Date | Name | Ticker | Shares | Change | Value | Change | Price |
| 06/30/2023 | Revance Therapeutics, Inc. | RVNC | 4,652,776 | 339,880 | 117,761,761,000 | 117,645,312,000 | $25,310.00 |
| 09/30/2022 | Revance Therapeutics, Inc. | RVNC | 4,312,896 | 609,841 | 116,449,000 | 65,273,000 | $27.00 |
| 06/30/2022 | Revance Therapeutics, Inc. | RVNC | 3,703,055 | 57,744 | 51,176,000 | -19,908,000 | $13.82 |
| 03/31/2022 | Revance Therapeutics, Inc. | RVNC | 3,645,311 | 43,014 | 71,084,000 | 12,294,000 | $19.50 |
| 12/31/2021 | Revance Therapeutics, Inc. | RVNC | 3,602,297 | 17,392 | 58,790,000 | -41,086,000 | $16.32 |
| 09/30/2021 | Revance Therapeutics, Inc. | RVNC | 3,584,905 | -27,843 | 99,876,000 | -7,206,000 | $27.86 |
| 06/30/2021 | Revance Therapeutics, Inc. | RVNC | 3,612,748 | 372,577 | 107,082,000 | 15,255,000 | $29.64 |
| 12/31/2020 | Revance Therapeutics, Inc. | RVNC | 3,240,171 | 87,795 | 91,827,000 | 12,576,000 | $28.34 |
| 09/30/2020 | Revance Therapeutics, Inc. | RVNC | 3,152,376 | 257,993 | 79,251,000 | 8,570,000 | $25.14 |
| 06/30/2020 | Revance Therapeutics, Inc. | RVNC | 2,894,383 | 224,934 | 70,681,000 | 31,173,000 | $24.42 |
| 03/31/2020 | Revance Therapeutics, Inc. | RVNC | 2,669,449 | 139,403 | 39,508,000 | -1,555,000 | $14.80 |
| 12/31/2019 | Revance Therapeutics, Inc. | RVNC | 2,530,046 | 380,567 | 41,063,000 | 13,119,000 | $16.23 |
| 09/30/2019 | Revance Therapeutics, Inc. | RVNC | 2,149,479 | -99,665 | 27,944,000 | -1,228,000 | $13.00 |
| 06/30/2019 | Revance Therapeutics, Inc. | RVNC | 2,249,144 | 146,444 | 29,172,000 | -3,966,000 | $12.97 |
| 03/31/2019 | Revance Therapeutics, Inc. | RVNC | 2,102,700 | 358,343 | 33,138,000 | -1,976,000 | $15.76 |
| 12/31/2018 | Revance Therapeutics, Inc. | RVNC | 1,744,357 | 237,562 | 35,114,000 | -2,330,000 | $20.13 |
| 09/30/2018 | Revance Therapeutics, Inc. | RVNC | 1,506,795 | 28,683 | 37,444,000 | -3,130,000 | $24.85 |
| 06/30/2018 | Revance Therapeutics, Inc. | RVNC | 1,478,112 | 155,595 | 40,574,000 | -160,000 | $27.45 |
| 03/31/2018 | Revance Therapeutics, Inc. | RVNC | 1,322,517 | 81,914 | 40,734,000 | -3,619,000 | $30.80 |
| 12/31/2017 | Revance Therapeutics, Inc. | RVNC | 1,240,603 | 216,268 | 44,353,000 | 16,133,000 | $35.75 |
| 09/30/2017 | Revance Therapeutics, Inc. | RVNC | 1,024,335 | 92,712 | 28,220,000 | 28,195,405 | $27.55 |
| 06/30/2017 | Revance Therapeutics, Inc. | RVNC | 931,623 | 63,505 | 24,595 | -18,031,405 | $0.03 |
| 03/31/2017 | Revance Therapeutics, Inc. | RVNC | 868,118 | 42,466 | 18,056,000 | 965,000 | $20.80 |
| 12/31/2016 | Revance Therapeutics, Inc. | RVNC | 825,652 | 13,829 | 17,091,000 | 3,931,000 | $20.70 |
| 09/30/2016 | Revance Therapeutics, Inc. | RVNC | 811,823 | 811,823 | 13,160,000 | 13,160,000 | $16.21 |
| 06/30/2016 | Revance Therapeutics, Inc. | RVNC | 783,706 | 79,366 | 10,659,000 | -1,638,000 | $13.60 |
| 03/31/2016 | Revance Therapeutics, Inc. | RVNC | 704,340 | 704,340 | 12,297,000 | 12,297,000 | $17.46 |
| 12/31/2015 | Revance Therapeutics, Inc. | RVNC | 653,010 | 653,010 | 22,307,000 | 22,307,000 | $34.16 |
| 09/30/2015 | Revance Therapeutics, Inc. | RVNC | 0 | -448,457 | 0 | -14,342,000 | |
| 06/30/2015 | Revance Therapeutics, Inc. | RVNC | 448,457 | 30,685 | 14,342,000 | 5,681,000 | $31.98 |
| 03/31/2015 | Revance Therapeutics, Inc. | RVNC | 417,772 | 33,874 | 8,661,000 | 2,158,000 | $20.73 |
| 12/31/2014 | Revance Therapeutics, Inc. | RVNC | 383,898 | 65,636 | 6,503,000 | 351,000 | $16.94 |
| 09/30/2014 | Revance Therapeutics, Inc. | RVNC | 318,262 | 318,262 | 6,152,000 | 6,152,000 | $19.33 |
| 06/30/2014 | Revance Therapeutics, Inc. | RVNC | 228,026 | 228,026 | 7,753,000 | 7,753,000 | $34.00 |
| 03/31/2014 | Revance Therapeutics, Inc. | RVNC | 134,888 | 134,888 | 4,249,000 | 4,249,000 | $31.50 |
| << Prev Next >> |
|